Committed to scientific integrity, patient support services, patient advocacy, education and mentoring of experienced and inexperienced medical staff, GMCM’ purpose is to aid the planning, development, implementation and evaluation of standard of care for all patients receiving genetic services for personalized preventative care.
GMCM is located in a private practice in downtown Chicago, Illinois with over 30 years of combined experience in clinical research. GMCM is culturally competent and maintains the highest ethical standards with sensitivity to diverse social, religious and cultural beliefs. This has allowed GMCM to overcome the many challenges of diversified recruitment of patients and physicians.
The commitment to the development and maintenance of a healthy community has allowed GMCM to develop the Strategic Holistic Ongoing Partnership (SHOP) Program. This community outreach program identifies health needs and provides ongoing education, training and services to the healthcare professional as well as the community at large.
GMCM conducts evidence-based services that yield quality data/results, which ultimately provides the physician and any healthcare organization with a comprehensive service plan for their patients. GMCM embraces the importance of diversity in a clinical environment, while enhancing the quality of life for all populations who benefit from personalized preventative care.
People at a higher risk for cancer may have the option of having more frequent cancer screenings, avoiding specific risk factors, making lifestyle changes to lessen additional risk, taking preventive medication (chemoprevention), and/or having risk reducing surgeries in order to reduce their risk. Cancer screening panel includes:
Breast cancer is the most common female cancer, affecting approximately 1 in 8 women in the United States. Approximately 5-10% of breast cancers are hereditary. Hereditary cancers are caused by a mutation in a gene that can be passed on from generation to generation. Women who have an abnormal mutation can have up to an 87% risk of being diagnosed with breast cancer during their lifetimes.
Ovarian cancer is the ninth most common cancer in women, but it ranks fifth as the cause of cancer death in women. While most ovarian cancer does not run in the family, approximately 10-15% of ovarian cancer is hereditary. Hereditary cancers are caused by a mutation in a gene that can be passed on from generation to generation. Women who have an abnormal can have up to a 44% risk of being diagnosed with breast cancer during their lifetimes.
Colorectal cancer is cancer that starts in either the colon or the rectum. Most colorectal cancer does not run in the family, but approximately 5% of colorectal cancer is hereditary. Hereditary cancers are caused by a mutation in a gene that can be passed on from generation to generation.
Approximately 1 in 76 people will develop pancreatic cancer in their lifetime. Most pancreatic cancer develops by chance and does not run in families. However, some pancreatic cancers are hereditary. Hereditary cancers are caused by a mutation in a gene that can be passed on from generation to generation and cause up to 10% of Pancreatic Cancers
Endometrial cancer (cancer of the lining of the uterus) is the most common cancer of the female reproductive organs. Approximately 1 in 41 women will develop endometrial cancer. While most endometrial cancer does not run in the family, 1-5% of endometrial cancer is hereditary.
Gastric cancer (also called stomach cancer) is cancer that starts in the stomach. Most stomach cancers do not run in the family, but some stomach cancers are hereditary and gene abnormalities can significantly increase the risk of one or more types of gastric cancers.
Skin cancer is often divided into two categories: non-melanoma and melanoma. Non-melanoma skin cancers are the most common cancers in men and women. There are two types of non-melanoma skin cancer: basal cell carcinoma and squamous cell carcinoma.
Other than skin cancer, prostate cancer is the most common type of cancer found in American men. Prostate cancer is the second leading cause of death in men. Most cases of prostate cancer develop by chance and do not run in families. However, a portion of prostate cancers are hereditary. Hereditary cancers are caused by a mutation in a gene that can be passed on from generation to generation. Men who have an abnormal gene are as much as 20 times more likely to develop prostate cancer.
All materials for the swabs/mouth rinses are provided including marketing material and prepaid shipping packaging. There is absolutely NO start up cost to the physician or any cost to continue providing these services.
These test improve clinical judgment and help physicians form a more accurate, comprehensive and effective treatment regimen with the goal of enhancing a patient’s quality of life.
A. A positive test result means that the patient has the mutation and is at higher risk than the average patient for particular gene. It does not guarantee the patient will inherit the disease or will in fact get cancer.
A. A negative test result means that the patient doesn’t have a particular mutation that will affect the patient. It doesn’t mean you will not get the cancer/disease, it just means IF you do, it was not genetically related and was caused by environmental or social reasons.
A. The patient is pre-screened and goes through a prior authorization with the patient’s insurance to identify if the patient qualifies for 100% coverage. If the patient has any financial responsibility towards their test sample, they are contacted directly to offer financial payment options or can opt out at anytime prior to the laboratory running the sample to prevent getting billed.
A. There are absolutely no start up costs for a physician, clinic or organization to offer these services to their patients. GreenMCMeds provides all kits, marketing material and pre-paid shipping packaging labels to mail samples to our testing laboratory.
A. Depending on the clinics supporting staff, either the physician, or the appointed staff will identify qualified patients for the day based on family history, and/or insurance coverage from a provided accepted insurance list for that specific test. Upon a successful candidate list for the screening assessment service, explain the service being offered to the patient during the encounter, gather patient/physician signatures (Requisition/Consent Forms), make/print copy of patient’s insurance and perform the mouth swab/rinse on patient.
DISCLAIMER: GreenMCMeds does not partake in cultivation or dispensing of cannabis in no way, shape, or form, nor are we affiliated with any dispensaries or cultivation sites.